Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphoma

On the basis of the benefits of frontline radiation in early-stage, extranodal natural killer (NK)/T-cell lymphoma (ENKTL), we conducted the trial of concurrent chemoradiotherapy (CCRT) followed by three cycles of gemcitabine, dexamethasone and cisplatin (GDP). Thirty-two patients with newly diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Q-H, Zhou, S-Q, Du, W, Liang, G, Lei, Y, Luo, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315894/
https://www.ncbi.nlm.nih.gov/pubmed/25501024
http://dx.doi.org/10.1038/bcj.2014.88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315894/
https://www.ncbi.nlm.nih.gov/pubmed/25501024
http://dx.doi.org/10.1038/bcj.2014.88

Ejemplares similares